Business
Medifast Announces Planned Leadership Transition
BALTIMORE, January 05, 2026--Medifast, Inc. (NYSE: MED) today announced a planned leadership transition designed to provide continuity and stability as the company continues its evolution toward metabolic health.
About this update from Medifast Inc
[{"type":"image","alt":"","displaySize":"","headline":null,"caption":"","credit":null,"className":"","disableSlideshowImg":false,"size":{"original":{"width":2364,"height":827,"url":"https://media.zenfs.com/en/business-wire.com/a13ea7a7f3dccba2d86a427cda499eb4"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/iVBW6AcyzXIcy9OwjqeOmA--/YXBwaWQ9aGlnaGxhbmRlcjt3PTk2MDtoPTMzNjtjZj13ZWJw/https://media.zenfs.com/en/business-wire.com/a13ea7a7f3dccba2d86a427cda499eb4","width":960,"height":336},"lightbox":{"url":"https://s.yimg.com/ny/api/res/1.2/TCkcJgbNRU.Jn6ugypQBig--/YXBwaWQ9aGlnaGxhbmRlcjt3PTI0MDA7aD04NDA7Y2Y9d2VicA--/https://media.zenfs.com/en/business-wire.com/a13ea7a7f3dccba2d86a427cda499eb4","width":1200,"height":420}},"lazy":false},{"type":"text","content":"Nicholas Johnson Appointed President, and Expected to Succeed Dan Chard as CEO in June 2026; Chard to Remain Chairman","length":117,"tagName":"p","attribs":{}},{"type":"text","content":"BALTIMORE, January 05, 2026--(BUSINESS WIRE)--Medifast, Inc. (NYSE: MED) today announced a planned leadership transition designed to provide continuity and stability as the company continues its evolution toward metabolic health.","length":229,"tagName":"p"},{"type":"text","content":"Medifast Chairman & Chief Executive Officer Dan Chard has informed the Board of Directors that he plans to step down as Chief Executive Officer in June 2026. Chard will continue to serve as Chairman of the Board following the transition.","length":241,"tagName":"p"},{"type":"text","content":"The Board has appointed Medifast’s Chief Field Operations Officer Nicholas Johnson as President of Medifast, effective immediately. Johnson will work closely with Chard and the Board during a deliberate transition period and is expected to assume the role of Chief Executive Officer following Chard’s departure.","length":311,"tagName":"p"},{"type":"text","content":""This decision comes at a moment when I feel confidence in the direction of Medifast, the strength of our leadership team, and the path we are on as a metabolic health company," said Dan Chard, Chief Executive Officer of Medifast. "Over the past two years, we have repositioned the business, strengthened our scientific foundation, and reinforced the coach-led model that differentiates us. Nick has played an instrumental role in that work, leading our shift to a metabolic h...